Верапамил

Barton BM, Gitlin MJ. Verapamil in treatment-resistant mania: an open trial. J Clin Psychopharmacol 1987; 7:101.

Dubovsky SL, Franks RD, Lifschitz M, et al. Effectiveness of verapamil in the treatment of a manic patient. Am J Psychiatry 1982; 139:502.

Dubovsky SL, Franks RD, Allen S, et al. Calcium antagonists in mania: a double-blind study of verapamil. Psychiatry Res 1986; 18:309.

Giannini AJ, Houser WL, Loiselle RH, et al. Antimanic effects of verapamil. Am J Psychiatry 1984; 141:1602.

Gitlin M, Weiss J. Verapamil as maintenance treatment in bipolar illness: a case report. J Clin Psychopharmacol 1984; 4:341.

Дисульфирам.

Branchey L, Davis W, Lee KK, et al. Psychiatric complications of disulfiram treatment. Am J Psychiatry 1987; 14:1310.

Eneanya DL, Bianchine JR, Duran DO, et al. The actions and metabolic fate of disulfiram. Ann Rev Pharmacol Toxicol 1981; 21:575.

Fisher CM. Catatonia due to disulfiram toxicity. Arch Neurol 1989; 46:798.

Fuller RK, Branchey L, Brightwell DR, et al. Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA 1986; 256:1449.

Fuller RK, Roth HP. Disulfiram for the treatment of alcoholism. Ann Intern Mod 1979; 90:901.

Kirubakaran V, Liskow B, Mayfield D, et al. Case report of acute disulfiram overdose. Am J Psychiatry 1983; 140:1513.

Sellers EM, Naranjo СA, Peachey JE. Drugs to decrease alcohol consumption. N Engl J Med 1981;305:1255.

Донепезил.

Roger SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: result of a multicentre, randomized, double-blind, placebo-controlled trial. The Donepezil Study Group. Dementia 1996; 7:293.

Такрин.

Knapp MJ, Knopman DS, Solomon PR, et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271:985.

Watkins PB, Zimmerman HJ, Knapp MJ, et al. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994; 271:992.

Аддерал.

Pelham WE, Aronoff HR, Midlam JK, et al. A comparison of ritalin and Adderall: efficacy and time course in children with attention-deficit/hyperactivity disorder. Pediatrics 1999; 103:43.

Pliszka SR. The use of psychostimulants in the pediatric patient. Pediatr Clin North Am 1998; 45:1085.

Swanson J, Wigal S, Greenhill L, et al. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting. Psychopharmacol Bull 1998; 34:55.